Recent Updates
Recently added Catalysts
SYRE Positive Sentiment Score: 75/100

Spyre Therapeutics to Present at Upcoming Investor Conference Spyre Therapeutics, Inc. ( Spyre ) (NASDAQ: SYRE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to...

Tuesday, November 28, 2023 1 min read
Key Takeaway: Spyre Therapeutics, Inc. (NASDAQ: SYRE), a biotechnology firm, announced that its CEO, Cameron Turtle, will present at an upcoming investor conference. The company focuses on developing antibody therapeutics aimed at transforming treatments for inflammatory bowel disease (IBD). The conference's webcast will be accessible on the Spyre website, with a replay available for 90 days post-event. This participation reflects Spyre's commitment to engaging with its investment community.

Market Sentiment Analysis

POSITIVE FACTORS

  • Spyre Therapeutics is advancing a pipeline of antibody therapeutics.
  • The company's work has the potential to transform treatment for IBD.
  • CEO Cameron Turtle's participation in the conference indicates company transparency and engagement with investors.

Full Press Release Details

WALTHAM, Mass. , Nov. 28, 2023 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre") (NASDAQ: SYRE ), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease ("IBD"), today announced that Cameron Turtle , D.Phil., CEO of Spyre Therapeutics will participate in an upcoming investor conference:
The webcast for this conference may be accessed at the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com. A replay of the webcast will be available for 90 days following the conference.
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
SOURCE Spyre Therapeutics, Inc.

21 %

Frequently Asked Questions

What is Spyre Therapeutics focused on?

Spyre Therapeutics is focused on developing antibody therapeutics for inflammatory bowel disease.

Who is the CEO of Spyre Therapeutics?

Cameron Turtle, D.Phil., is the CEO of Spyre Therapeutics.

Where can I access the investor conference webcast?

The investor conference webcast can be accessed on the Spyre website under 'Events & Presentations.'

How long will the webcast replay be available?

The replay of the webcast will be available for 90 days after the conference.

Tags: SYRE Viatris Investor Conferences Healthcare Spyre Therapeutics investor conference antibody therapeutics IBD
Last updated: Nov 28, 2023